Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 ("INTEGRA") study at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San ...

For mild allergic reaction symptoms ... Resistance means that Descovy will be less effective at treating HIV, or it may no longer be effective at all. PrEP treatment refers to taking an HIV ...

The Mount Sinai team will next study and test specific approaches to reactivate dormant HIV and determine if it is possible to reduce the reservoir of infected cells. The study was supported by ...

Determinants of HIV cell tropism & chemokine receptor usage ... SDF-1α-mediated chemotaxis of cancer cells. Antiarthritis & allergy: CXCR4 inhibitors AMD3100 and T140 are effective in mitigating ...

A research group led by Professor Wei Li from the Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Toho ...

Researchers evaluated the potential clinical impact and cost-effectiveness of administering long-acting, injectable ...

The global HIV antivirals market is experiencing substantial growth, fueled by rising global awareness, advancements in pharmaceutical research, and the increasing adoption of innovative treatment ...